We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
31 hedge funds and large institutions have $2.56M invested in CASI Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
14% more capital invested
Capital invested by funds: $2.25M → $2.56M (+$318K)
11% more funds holding
Funds holding: 28 → 31 (+3)
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$38.1K |
| 2 |
Renaissance Technologies
New York
|
+$11.2K |
| 3 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$7.76K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.51K |
| 5 |
WJA
Williams Jones & Associates
New York
|
+$2.17K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.2K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$492 |
